Expression of LAIR-1 (CD305) on Human Blood Monocytes as a Marker of Hepatic Cirrhosis Progression

Figure 3

LAIR-1 expression in blood monocyte subsets. LAIR-1 expression in peripheral blood of cirrhotic patients () or healthy controls () was analyzed by flow cytometry. The population of monocytes was gated on the base of morphology and CD14⁺ expression. (a) Representative dot-plot of CD14 and CD16 expression pattern on blood monocytes and gates selecting the three different CD14/CD16 subsets CD14⁺⁺CD16^- (classic), CD14⁺⁺CD16⁺ (intermediate), and CD14^lowCD16⁺ (nonclassical) monocytes, in healthy controls and cirrhotic patients. Percentages refer to the mean ratio of cell subpopulations gated on the total population of CD14+ cells. (b) The LAIR-1 expression was compared between control and cirrhosis within each monocyte CD14/CD16 subset (horizontal lines indicate the mean and SEM) (c) or between healthy controls and cirrhotic patients attending to their clinical progression, compensated (Comp-C) or decompensated (Decomp-C) cirrhosis (bars represent the mean and SEM). Two-sided Mann-Whitney test: , , and , between cirrhotic patients and healthy controls.

(a)

(b)

(c)